000 02324cam a2200277 a 4500
001 vtls003219995
003 MY-SjTCS
005 20200226114827.0
008 110707s2010 enka b 001 0 eng d
020 _a9780521895330 (hbk.)
039 9 _a201110171532
_bshuhada
_c201110151616
_dshuhada
_c201110051504
_dizani
_y201107071332
_zhaizir
082 0 4 _a616.89806
_bANT 2010
245 0 0 _aAntipsychotic trials in schizophrenia :
_bthe CATIE project /
_cedited by T. Scott Stroup, Jeffrey A. Lieberman.
260 _aCambridge :
_bCambridge University Press,
_c2010.
300 _axvii, 312 p. :
_bill. ;
_c24 cm.
490 1 _aCambridge medicine
504 _aIncludes bibliographical references and index.
505 8 _aMachine generated contents note: Introduction: Rationale for an independent, pragmatic study of antipsychotic treatments Jeffrey Lieberman; 1. Study design and protocol development process Scott Stroup, Joe McEvoy and Jeffrey Lieberman; 2. Statistical considerations Sonia Davis and Gary Koch; 3. Efficacy and effectiveness Joe McEvoy, Scott Stroup and Jeffrey Lieberman; 4. Measures of global effectiveness, cost-effectiveness Bob Rosenheck; 5. Quality of life and recovery Marvin Swartz; 6. Neurocognition Rich Keefe; 7. Vocational outcomes Sandra Resnick et al.; 8. Family outcomes Deborah Perlick et al.; 9. Neurologic side effects Stan Caroff, Del Miller and Bob Rosenheck; 10. Metabolic side effects and risk of cardiovascular disease Jonathan Meyer, Don Goff and Joe McEvoy; 11. Substance abuse Fred Reimherr and Marvin Swartz; 12. Violence Jeff Swanson and Richard van Dorn; 13. Genetics Patrick Sullivan; 14. Human subjects considerations Scott Stroup, Scott Kim and Paul Appelbaum; 15. Pharmacokinetics Bruce Pollock; 16. Implications of the CATIE project on research design and implementation Scott Stroup and Jeffrey Lieberman; 17. Conclusions-impact of the study and implications for dissemination, practice and policy formation Scott Stroup, Bob Rosenheck and Jeffrey Lieberman; Index.
610 2 0 _aCATIE Project.
_956344
650 0 _aAntipsychotic drugs
_xTesting.
650 0 _aSchizophrenia
_xChemotherapy.
_956345
700 1 _aStroup, T. Scott,
_d1960-
_956346
700 1 _aLieberman, Jeffrey A.,
_d1948-
_924201
830 0 _aCambridge medicine.
_953395
920 _aSMN : 167270
999 _c138754
_d138754